India Ranbaxy recalls Nitrofurantoin Capsules in U.S.
MUMBAI May 2 (Reuters) - India-based drug maker Ranbaxy Laboratories (RANB.BO) said on Saturday it is recalling all lots of Nitrofurantoin Capsules, an antibiotic, currently in the U.S. market.
A statement from the company said "certain lots of the product were determined to not be in conformity with the approved laboratory specifications," but it had decided "to recall all the lots."
It added that there was a remote possibility that the non-conforming product may increase nausea and vomiting.
Ranbaxy, in which Japanese drugmaker Daiichi Sankyo (4568.T) last year bought a controlling 64 percent stake, said last week it expected net losses of about $150 million in 2009 and also said revenue would fall 9 percent to $1.4 billion. [ID:nDEL190239]
(Reporting by Ruchira Singh; Editing by Valerie Lee)
- South Korea's Park says conduct of ferry crew tantamount to murder |
- Putin playing the long game over Russian kin in Ukraine
- Japan PM makes offering to Yasukuni Shrine, angers China, South Korea
- Ukraine peace deal falters as rebels show no sign of surrender |
- Cyclone threatens to disrupt search for missing Malaysian plane |